Ranbaxy Of India Plans To Launch Actos Generic In U.S. In 2012
This article was originally published in PharmAsia News
Executive Summary
India's Ranbaxy Laboratories said it expects to launch its generic version of Takeda Pharmaceutical's Actos (pioglitazone) diabetes drug in the United States in 2012